靶向肿瘤血管：现实还是梦想？ - Suppr

Suppr

超能文献

Targeting tumor vasculature: reality or a dream?

作者信息

Satchi-Fainaro Ronit

出版信息

J Drug Target. 2002 Nov;10(7):529-33. doi: 10.1080/1061186021000051062.

DOI:10.1080/1061186021000051062

PMID:12683719

Abstract

摘要

相似文献

Targeting tumor vasculature: reality or a dream?

J Drug Target. 2002 Nov;10(7):529-33. doi: 10.1080/1061186021000051062.

[Targeting blood vessels for treatment of cancer...].

J Pharm Belg. 2003;58(3):79-80.

Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.

Drug Discov Today. 2003 Sep 15;8(18):827-8. doi: 10.1016/s1359-6446(03)02763-6.

Imaging tumor angiogenesis.

J Clin Invest. 2006 Oct;116(10):2585-7. doi: 10.1172/JCI30058.

Vascular Detransformation for Cancer Therapy.

Trends Cancer. 2019 Aug;5(8):460-463. doi: 10.1016/j.trecan.2019.05.007. Epub 2019 Jun 14.

Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):241-53. doi: 10.2174/1568008013341073.

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.

Trends Pharmacol Sci. 2002 Dec;23(12):576-82. doi: 10.1016/s0165-6147(02)02109-0.

Inhibition of vascularization in tumor growth.

Phys Rev Lett. 2002 Nov 18;89(21):218101. doi: 10.1103/PhysRevLett.89.218101. Epub 2002 Nov 1.

Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?

Int J Dev Biol. 2011;55(4-5):563-7. doi: 10.1387/ijdb.103231rh.

Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.

J Clin Neurosci. 2009 Sep;16(9):1119-30. doi: 10.1016/j.jocn.2009.02.009. Epub 2009 Jun 24.

引用本文的文献

Apoptotic activities in soft tissue sarcoma: immunohistochemical study and their association with tumour characteristics.

Malays J Med Sci. 2013 Mar;20(2):10-6.

Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

PLoS One. 2009;4(4):e5233. doi: 10.1371/journal.pone.0005233. Epub 2009 Apr 21.

Immunotherapy of malignant brain tumors.

Immunol Rev. 2008 Apr;222:70-100. doi: 10.1111/j.1600-065X.2008.00603.x.

Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.

Pharm Res. 2004 Jul;21(7):1153-9. doi: 10.1023/b:pham.0000033001.49737.b7.

Fishing for novel angiogenic therapies.

Br J Pharmacol. 2003 Oct;140(4):585-94. doi: 10.1038/sj.bjp.0705496.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Targeting tumor vasculature: reality or a dream?

J Drug Target. 2002 Nov;10(7):529-33. doi: 10.1080/1061186021000051062.

[Targeting blood vessels for treatment of cancer...].

J Pharm Belg. 2003;58(3):79-80.

Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.

Drug Discov Today. 2003 Sep 15;8(18):827-8. doi: 10.1016/s1359-6446(03)02763-6.

Imaging tumor angiogenesis.

J Clin Invest. 2006 Oct;116(10):2585-7. doi: 10.1172/JCI30058.

Vascular Detransformation for Cancer Therapy.

Trends Cancer. 2019 Aug;5(8):460-463. doi: 10.1016/j.trecan.2019.05.007. Epub 2019 Jun 14.

Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Curr Drug Targets Immune Endocr Metabol Disord. 2001 Nov;1(3):241-53. doi: 10.2174/1568008013341073.

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.

Trends Pharmacol Sci. 2002 Dec;23(12):576-82. doi: 10.1016/s0165-6147(02)02109-0.

Inhibition of vascularization in tumor growth.

Phys Rev Lett. 2002 Nov 18;89(21):218101. doi: 10.1103/PhysRevLett.89.218101. Epub 2002 Nov 1.

Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?

Int J Dev Biol. 2011;55(4-5):563-7. doi: 10.1387/ijdb.103231rh.

Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.

J Clin Neurosci. 2009 Sep;16(9):1119-30. doi: 10.1016/j.jocn.2009.02.009. Epub 2009 Jun 24.

引用本文的文献

Apoptotic activities in soft tissue sarcoma: immunohistochemical study and their association with tumour characteristics.

Malays J Med Sci. 2013 Mar;20(2):10-6.

Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.

PLoS One. 2009;4(4):e5233. doi: 10.1371/journal.pone.0005233. Epub 2009 Apr 21.

Immunotherapy of malignant brain tumors.

Immunol Rev. 2008 Apr;222:70-100. doi: 10.1111/j.1600-065X.2008.00603.x.

Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.

Pharm Res. 2004 Jul;21(7):1153-9. doi: 10.1023/b:pham.0000033001.49737.b7.

Fishing for novel angiogenic therapies.

Br J Pharmacol. 2003 Oct;140(4):585-94. doi: 10.1038/sj.bjp.0705496.